Follow:
RSS
Email
Twitter
Curaxis Pharmaceutical Corp. :: Alzheimer's News, Insight, and Information
  • Home
  • About Us
  • Media
  • Uncategorized

Archive for December, 2009

  • Alzheimer’s: Destructive Amyloid-Beta Protein May Also Be Essential for Normal Brain Function on December 10th, 2009
  • biOasis Executes Agreement With Fleet Bioprocessing Ltd. to Develop Diagnostic Test for Alzheimer’s Disease on December 9th, 2009
  • Bayer Initiates Enrollment in Phase III Alzheimer’s Trial on December 9th, 2009
  • Strategies to Protect New Brain Cells Against Alzheimer’s Disease on December 3rd, 2009
  • Dementia Risk Higher for NFL Players on December 2nd, 2009
  • What Is Alzheimer’s Disease? on December 1st, 2009
  • Going high-tech to track Alzheimer’s patients on December 1st, 2009
Newer Entries »

  • Recent Articles

    • Alzheimer’s brain tangles offer clue to worsening
    • Cognitive Impairment Strikes Men More
    • Exercise Protects Against Alzheimer’s
    • Spinal taps may be useful in predicting brain disorders
    • New Study Explores Link Between Type 2 Diabetes, Alzheimer’s
  • Categories

  • Archives

    • September 2010 (3)
    • August 2010 (11)
    • July 2010 (17)
    • June 2010 (20)
    • May 2010 (20)
    • April 2010 (19)
    • March 2010 (16)
    • February 2010 (8)
    • January 2010 (16)
    • December 2009 (17)
    • November 2009 (1)
  • Curaxis Pharmaceutical Corp.

    Curaxis Pharmaceutical Corporation is a specialty company dedicated to finding cures for major age-related diseases with it initial focus is Alzheimer’s Disease (or AD). For more, visit www.curaxispharma.com


  • Warning: strpos() expects parameter 1 to be string, array given in /usr/www/users/beavins/blog/wp-includes/rss.php on line 577
  • Follow Us On Twitter

    • News:: New Study Explores Link Between Type 2 Diabetes, Alzheimer's http://bit.ly/bDgU67
    • News:: Alzheimer's drug could put the brakes on deadly disease http://bit.ly/dgEAY0
    • News:: New Alzheimer's test http://blog.curaxispharma.com/2010/08/17/new-alzheimers-test/

About

Curaxis Pharmaceutical Corporation is a specialty pharmaceutical company dedicated to finding cures for major age-related diseases. Our initial focus is Alzheimer’s Disease (or AD). Our lead product is a patented treatment that has shown the potential for treating and halting the progression of this devastating disease. Today, over 5,300,000 Americans suffer with Alzheimer’s Disease. It is estimated that more than $100 billion is spent annually in the United States to treat and care for those with this ailment. Sadly, these numbers are growing every day as the situation for many patients and their families grows desperate, despite the millions of dollars spent annually to find the answer to effectively treating this disease.
  • Videos

Search

Copyright © 2012 Curaxis Pharmaceutical Corp.